HOME >> MEDICINE >> NEWS
Inflammation of placental membranes may be risk factor for cerebral palsy

In an article in the November 26 JAMA, researchers found that chorioamnionitis, or inflammation of the placental membranes, is associated with a four-fold increased risk of cerebral palsy among term and near term infants.

According to background information in the article, cerebral palsy (CP), a group of nonprogressive motor impairment syndromes caused by lesions of the brain arising early in development, occurs in 1 to 2.4 per 1000 live births. Half of all cases of CP occur in term infants, for whom risk factors have not been clearly defined. Recent studies have suggested a possible role of chorioamnionitis. The researchers in this study examined whether clinical chorioamnionitis increases the risk of CP in term and near-term infants.

The study, conducted by Yvonne W. Wu, M.D., M.P.H., of the University of California, San Francisco, and colleagues, included data from 327 infants (including 109 with moderate to severe CP and 218 control infants) born at 36 or more weeks' gestation between January 1, 1991, and December 31, 1998, in the Kaiser Permanente Medical Care Program. This managed care organization providing care for more than 3 million residents of northern California. Case patients were identified from electronic records and confirmed by chart review by a child neurologist, and comprised all children with moderate to severe spastic or impairment of movement CP not due to brain injury occurring after birth or developmental abnormalities. Controls were randomly selected from the study population.

The researchers found that most CP cases had some paralysis; 87 percent had been diagnosed by a neurologist and 83 percent had undergone neuroimaging. Chorioamnionitis, considered present if a treating physician made a diagnosis of chorioamnionitis or endometritis clinically, was noted in 14 percent of cases and 4 percent of controls. Independent risk factors for CP included chorioamnionitis (4.1 times increased risk); intrauterine growth re
'"/>

Contact: Jennifer O'Brien
415-476-8432
JAMA and Archives Journals
25-Nov-2003


Page: 1 2

Related medicine news :

1. Inflammation elevates risk of cardiac death in rheumatoid arthritis patients
2. Inflammation may increase stroke risk in men with hypertension
3. Inflammation reduced after just two weeks on statin drug
4. Study Suggests Inflammation Signs Can Show Who Will Develop Diabetes
5. Antibiotics Reduce Inflammation In Heart Disease But Effect On Heart Attacks Remains Unproven
6. Scientists Discover How Aspirin Reduces Inflammation
7. Study Ties Cerebral Palsy To Inflammation And Blood-Clotting Abnormalities
8. Snipping Inflammation In The Bud; New Agents May Provide Relief
9. Cultural and social factors influence prostate cancer treatment
10. Study finds factors linked to substance use disorder relapse among health care professionals
11. UW research shows risk factors for relapse among health care professionals who abuse drugs

Post Your Comments:
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma Applied ... Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress yesterday ... (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web Marketing ... All-Stars Summit. Google Partners is the platform for search marketing agencies to communicate ... and tools necessary to run successful search marketing campaigns. Google Partners also affords ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has officially been accredited by ... recommendations.” No recommendations means CARF found no areas in the OHR program that needed ... 3% of all facilities receive. In addition, Ocean Hills was granted the maximum certification ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... of Medicine at Mount Sinai Earns National Cancer Institute Designation , The Tisch ... been named a National Cancer Institute (NCI)-designated cancer center. TCI joins an elite ...
(Date:7/30/2015)... ... July 30, 2015 , ... 1Heart Caregiver Services LLC is offering its ... Make Money in the Booming Homecare Business.” This will be held in its main ... , The event will be hosted by 1Heart’s very own Randy Clarito (Director of ...
Breaking Medicine News(10 mins):Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2
(Date:7/30/2015)... 30, 2015  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, today ... year 2015 financial results after the market close on ... follow on the same day at 4:30 p.m. ET. ... Chief Executive Officer, and Rick Eiswirth , Chief ...
(Date:7/30/2015)... , Net Sales of $1.17 billion represent a decrease of ... of 5.7% constant currency , Reported net loss per ... per share were $1.59, an increase of 0.6% over the ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ...  The Company reported second quarter net sales of $1.17 billion, ...
(Date:7/29/2015)... Ill. , July 30, 2015  Astellas ... ACTIVE study evaluating the efficacy and safety of ... CRESEMBA® (isavuconazonium sulfate), under development for adults with ... Results from the study demonstrated that the trial ... in overall treatment response in isavuconazole-treated patients at ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5
Cached News: